메뉴 건너뛰기




Volumn 5, Issue SPEC. ISSUE 2, 2011, Pages 93-98

Medicinal chemistry and actions of dual and pan PPAR modulators

Author keywords

Diabetes mellitus; Fibrates; Medicinal chemistry; PPAR agonists; Thiazolidinediones

Indexed keywords

ABC TRANSPORTER A1; ALEGLITAZAR; BEZAFIBRATE; CIPROFIBRATE; CLOFIBRATE; DUAL PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATOR; FARGLITAZAR; FENOFIBRATE; GEMFIBROZIL; GLITAZONE DERIVATIVE; HIGH DENSITY LIPOPROTEIN; IMIGLITAZAR; LIGAND; LOW DENSITY LIPOPROTEIN; MURAGLITAZAR; NAVEGLITAZAR; NETOGLITAZONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RAGAGLITAZAR; TESAGLITAZAR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 80455125821     PISSN: None     EISSN: 18741045     Source Type: Journal    
DOI: 10.2174/1874104501105010093     Document Type: Review
Times cited : (55)

References (28)
  • 2
    • 0036183630 scopus 로고    scopus 로고
    • The mechanisms of action of PPARs
    • Berger, J.; Moller, D. E. The mechanisms of action of PPARs. Annu. Rev. Med., 2002, 53, 409-435.
    • (2002) Annu. Rev. Med. , vol.53 , pp. 409-435
    • Berger, J.1    Moller, D.E.2
  • 3
    • 32644460092 scopus 로고    scopus 로고
    • From molecular action to physiological outputs: Peroxisome proliferator- activated receptors are nuclear receptors at the crossroads of key cellular functions
    • Feige, J. N.; Gelman, L.; Michalik, L.; Desvergne, B.; Wahli, W. From molecular action to physiological outputs: peroxisome proliferator- activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res., 2006, 45, 120-159
    • (2006) Prog. Lipid Res. , vol.45 , pp. 120-159
    • Feige, J.N.1    Gelman, L.2    Michalik, L.3    Desvergne, B.4    Wahli, W.5
  • 4
    • 0025132245 scopus 로고
    • Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
    • Issemann, I.; Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347, (6294), 645-650.
    • (1990) Nature , vol.347 , Issue.6294 , pp. 645-650
    • Issemann, I.1    Green, S.2
  • 5
    • 34547604561 scopus 로고    scopus 로고
    • Transcription coactivators for peroxisome proliferator-activated receptors
    • Yu, S.; Reddy, J. K. Transcription coactivators for peroxisome proliferator-activated receptors. Biochim. Biophys. Acta, 2007, 1771, 936-951.
    • (2007) Biochim. Biophys. Acta. , vol.1771 , pp. 936-951
    • Yu, S.1    Reddy, J.K.2
  • 8
    • 16644370608 scopus 로고    scopus 로고
    • Design and synthesis of subtype- and species-selective peroxisome proliferator-activated receptor (PPAR) alpha ligands
    • Miyachi, H. Design and synthesis of subtype- and species-selective peroxisome proliferator-activated receptor (PPAR) alpha ligands. Yakugaku Zasshi. 2004,124: 803-813.
    • (2004) Yakugaku Zasshi , vol.124 , pp. 803-813
    • Miyachi, H.1
  • 9
    • 0026785388 scopus 로고
    • Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids
    • Schmidt, A.; Endo, N.; Rutledge, S. J.; Vogel, R.; Shinar, D.; Rodan, G. A. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol., 1992, 6, 1634-1641.
    • (1992) Mol. Endocrinol. , vol.6 , pp. 1634-1641
    • Schmidt, A.1    Endo, N.2    Rutledge, S.J.3    Vogel, R.4    Shinar, D.5    Rodan, G.A.6
  • 10
    • 4744340732 scopus 로고    scopus 로고
    • Impact of genetic variation of PPARgamma in humans
    • Meirhaeghe, A.; Amouyel, P. Impact of genetic variation of PPARgamma in humans. Mol. Genet. Metab., 2004, 83, 93-102.
    • (2004) Mol. Genet. Metab. , vol.83 , pp. 93-102
    • Meirhaeghe, A.1    Amouyel, P.2
  • 12
    • 36549038966 scopus 로고    scopus 로고
    • PPAR agonists: Multimodal drugs for the treatment of type-2 diabetes
    • Gross, B.; Staels, B. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab., 2007, 21, 687-710.
    • (2007) Best Pract. Res. Clin. Endocrinol. Metab. , vol.21 , pp. 687-710
    • Gross, B.1    Staels, B.2
  • 16
    • 33750511973 scopus 로고    scopus 로고
    • PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome
    • Fievet, C.; Fruchart, J. C.; Staels, B. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Curr. Opin. Pharmacol., 2006, 6, 606-614.
    • (2006) Curr. Opin. Pharmacol. , vol.6 , pp. 606-614
    • Fievet, C.1    Fruchart, J.C.2    Staels, B.3
  • 17
    • 34547661571 scopus 로고    scopus 로고
    • Peroxisome proliferatoractivated receptor structures: Ligand specificity, molecular switch and interactions with regulators
    • Zoete, V.; Grosdidier, A.; Michielin, O. Peroxisome proliferatoractivated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochim. Biophys. Acta, 2007, 1771, 915-925.
    • (2007) Biochim. Biophys. Acta. , vol.1771 , pp. 915-925
    • Zoete, V.1    Grosdidier, A.2    Michielin, O.3
  • 18
    • 33745957332 scopus 로고    scopus 로고
    • Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study
    • Kendall, D. M.; Rubin, C. J.; Mohideen, P.; Ledeine, J. M.; Belder, R.; Gross, J.; Norwood, P.; O'Mahony, M.; Sall, K.; Sloan, G.; Roberts, A.; Fiedorek, F. T.; DeFronzo, R. A. Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study. Diabetes Care, 2006, 29, 1016-1023.
    • (2006) Diabetes Care , vol.29 , pp. 1016-1023
    • Kendall, D.M.1    Rubin, C.J.2    Mohideen, P.3    Ledeine, J.M.4    Belder, R.5    Gross, J.6    Norwood, P.7    O'Mahony, M.8    Sall, K.9    Sloan, G.10    Roberts, A.11    Fiedorek, F.T.12    Defronzo, R.A.13
  • 19
    • 28144451163 scopus 로고    scopus 로고
    • Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus
    • Nissen, S. E.; Wolski, K.; Topol, E. J. Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. JAMA, 2005, 294, 2581-2586.
    • (2005) JAMA , vol.294 , pp. 2581-2586
    • Nissen, S.E.1    Wolski, K.2    Topol, E.J.3
  • 21
    • 35248816864 scopus 로고    scopus 로고
    • Tesaglitazar, a dual peroxisome proliferator- activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice
    • Chira, E. C.; McMillen, T. S.; Wang, S.; Haw, A., 3rd; O'Brien, K. D.; Wight, T. N.; Chait, A. Tesaglitazar, a dual peroxisome proliferator- activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice. Atherosclerosis, 2007, 195, 100-109.
    • (2007) Atherosclerosis , vol.195 , pp. 100-109
    • Chira, E.C.1    McMillen, T.S.2    Wang, S.3    Haw 3rd, A.4    O'Brien, K.D.5    Wight, T.N.6    Chait, A.7
  • 22
    • 33646269938 scopus 로고    scopus 로고
    • Tesaglitazar: A promising approach in type 2 diabetes
    • Cox, S. L. Tesaglitazar: a promising approach in type 2 diabetes. Drugs Today (Barc), 2006, 42, 139-146.
    • (2006) Drugs Today (Barc) , vol.42 , pp. 139-146
    • Cox, S.L.1
  • 23
    • 70350547900 scopus 로고    scopus 로고
    • Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats
    • Liao, J.; Soltani, Z.; Ebenezer, P.; Isidro-Carrion, A. A.; Zhang, R.; Asghar, A.; Aguilar, E.; Francis, J.; Hu, X.; Ferder, L.; Reisin, E., Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats. Nephron Exp. Nephrol., 2010, 114, e61-68.
    • (2010) Nephron Exp. Nephrol. , vol.114
    • Liao, J.1    Soltani, Z.2    Ebenezer, P.3    Isidro-Carrion, A.A.4    Zhang, R.5    Asghar, A.6    Aguilar, E.7    Francis, J.8    Hu, X.9    Ferder, L.10    Reisin, E.11
  • 24
    • 34547559826 scopus 로고    scopus 로고
    • Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice
    • Cha, D. R.; Zhang, X.; Zhang, Y.; Wu, J.; Su, D.; Han, J. Y.; Fang, X.; Yu, B.; Breyer, M. D.; Guan, Y. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. Diabetes, 2007, 56, 2036-2045.
    • (2007) Diabetes , vol.56 , pp. 2036-2045
    • Cha, D.R.1    Zhang, X.2    Zhang, Y.3    Wu, J.4    Su, D.5    Han, J.Y.6    Fang, X.7    Yu, B.8    Breyer, M.D.9    Guan, Y.10
  • 27
    • 26844499207 scopus 로고    scopus 로고
    • Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo
    • Egerod, F. L.; Nielsen, H. S.; Iversen, L.; Thorup, I.; Storgaard, T.; Oleksiewicz, M. B. Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo. Biomarkers, 2005, 10, 295-309.
    • (2005) Biomarkers , vol.10 , pp. 295-309
    • Egerod, F.L.1    Nielsen, H.S.2    Iversen, L.3    Thorup, I.4    Storgaard, T.5    Oleksiewicz, M.B.6
  • 28
    • 33745606757 scopus 로고    scopus 로고
    • The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats
    • Li, P. P.; Shan, S.; Chen, Y. T.; Ning, Z. Q.; Sun, S. J.; Liu, Q.; Lu, X. P.; Xie, M. Z.; Shen, Z. F. The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats. Br. J. Pharmacol., 2006, 148, 610-618.
    • (2006) Br. J. Pharmacol. , vol.148 , pp. 610-618
    • Li, P.P.1    Shan, S.2    Chen, Y.T.3    Ning, Z.Q.4    Sun, S.J.5    Liu, Q.6    Lu, X.P.7    Xie, M.Z.8    Shen, Z.F.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.